{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:09:20Z","timestamp":1790024960610,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["32003B_159863\/1"],"award-info":[{"award-number":["32003B_159863\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s40801-019-00175-6","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T02:02:37Z","timestamp":1576548157000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Drug Prescription in Older Swiss Men and Women Followed in Family Medicine"],"prefix":"10.1007","volume":"7","author":[{"given":"David","family":"Schnegg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9986-3249","authenticated-orcid":false,"given":"Nicolas","family":"Senn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2249-1245","authenticated-orcid":false,"given":"Olivier","family":"Bugnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0992-3165","authenticated-orcid":false,"given":"Jo\u00eblle","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-4538","authenticated-orcid":false,"given":"Yolanda","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"key":"175_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy7030126","author":"C Sirois","year":"2019","unstructured":"Sirois C, Domingues NS, Laroche ML, Zongo A, Lunghi C, Guenette L, et al. Polypharmacy Definitions for multimorbid older adults need stronger foundations to guide research, clinical practice and public health. Pharmacy. 2019. https:\/\/doi.org\/10.3390\/pharmacy7030126.","journal-title":"Pharmacy"},{"key":"175_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","volume":"78","author":"L Midao","year":"2018","unstructured":"Midao L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213\u201320. https:\/\/doi.org\/10.1016\/j.archger.2018.06.018.","journal-title":"Arch Gerontol Geriatr"},{"issue":"7","key":"175_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s40266-013-0073-0","volume":"30","author":"E Blozik","year":"2013","unstructured":"Blozik E, Rapold R, von Overbeck J, Reich O. Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland. Drugs Aging. 2013;30(7):561\u20138. https:\/\/doi.org\/10.1007\/s40266-013-0073-0.","journal-title":"Drugs Aging"},{"key":"175_CR4","doi-asserted-by":"publisher","first-page":"w20126","DOI":"10.4414\/smw.2019.20126","volume":"149","author":"R Schneider","year":"2019","unstructured":"Schneider R, Reinau D, Schur N, Blozik E, Fruh M, Signorell A, et al. Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data. Swiss Med Wkly. 2019;149:w20126. https:\/\/doi.org\/10.4414\/smw.2019.20126.","journal-title":"Swiss Med Wkly"},{"key":"175_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejim.2016.05.022","volume":"35","author":"CE Aubert","year":"2016","unstructured":"Aubert CE, Streit S, Da Costa BR, Collet TH, Cornuz J, Gaspoz JM, et al. Polypharmacy and specific comorbidities in university primary care settings. Eur J Intern Med. 2016;35:35\u201342. https:\/\/doi.org\/10.1016\/j.ejim.2016.05.022.","journal-title":"Eur J Intern Med"},{"key":"175_CR6","doi-asserted-by":"publisher","unstructured":"American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63(11):2227\u201346. https:\/\/doi.org\/10.1111\/jgs.13702.","DOI":"10.1111\/jgs.13702"},{"issue":"2","key":"175_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138. https:\/\/doi.org\/10.1093\/ageing\/afu145.","journal-title":"Age Ageing"},{"key":"175_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.archger.2018.06.009","volume":"78","author":"S Sakr","year":"2018","unstructured":"Sakr S, Hallit S, Haddad M, Khabbaz LR. Assessment of potentially inappropriate medications in elderly according to Beers 2015 and STOPP criteria and their association with treatment satisfaction. Arch Gerontol Geriatr. 2018;78:132\u20138. https:\/\/doi.org\/10.1016\/j.archger.2018.06.009.","journal-title":"Arch Gerontol Geriatr"},{"issue":"8","key":"175_CR9","doi-asserted-by":"publisher","first-page":"e105425","DOI":"10.1371\/journal.pone.0105425","volume":"9","author":"O Reich","year":"2014","unstructured":"Reich O, Rosemann T, Rapold R, Blozik E, Senn O. Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization. PLoS One. 2014;9(8):e105425. https:\/\/doi.org\/10.1371\/journal.pone.0105425.","journal-title":"PLoS One"},{"issue":"3","key":"175_CR10","doi-asserted-by":"publisher","first-page":"e019003","DOI":"10.1136\/bmjopen-2017-019003","volume":"8","author":"DO Riordan","year":"2018","unstructured":"Riordan DO, Aubert CE, Walsh KA, Van Dorland A, Rodondi N, Du Puy RS, et al. Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study. BMJ Open. 2018;8(3):e019003. https:\/\/doi.org\/10.1136\/bmjopen-2017-019003.","journal-title":"BMJ Open"},{"key":"175_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/1471-2458-14-329","volume":"14","author":"J Skoog","year":"2014","unstructured":"Skoog J, Midlov P, Borgquist L, Sundquist J, Halling A. Can gender difference in prescription drug use be explained by gender-related morbidity?: a study on a Swedish population during 2006. BMC Public Health. 2014;14:329. https:\/\/doi.org\/10.1186\/1471-2458-14-329.","journal-title":"BMC Public Health"},{"key":"175_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030305","author":"A Nunez-Montenegro","year":"2019","unstructured":"Nunez-Montenegro A, Montiel-Luque A, Martin-Aurioles E, Garcia-Dillana F, Krag-Jimenez M, Gonzalez-Correa JA. Evaluation of inappropriate prescribing in patients older than 65 years in primary health care. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8030305.","journal-title":"J Clin Med"},{"key":"175_CR13","doi-asserted-by":"publisher","first-page":"k4524","DOI":"10.1136\/bmj.k4524","volume":"363","author":"T Perez","year":"2018","unstructured":"Perez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T. Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study. BMJ. 2018;363:k4524. https:\/\/doi.org\/10.1136\/bmj.k4524.","journal-title":"BMJ"},{"issue":"4","key":"175_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/ageing\/afw074","volume":"45","author":"SG Morgan","year":"2016","unstructured":"Morgan SG, Weymann D, Pratt B, Smolina K, Gladstone EJ, Raymond C, et al. Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults. Age Ageing. 2016;45(4):535\u201342. https:\/\/doi.org\/10.1093\/ageing\/afw074.","journal-title":"Age Ageing"},{"key":"175_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-642-30726-3_9","volume":"214","author":"C Hofer-Duckelmann","year":"2012","unstructured":"Hofer-Duckelmann C. Gender and polypharmacotherapy in the elderly: a clinical challenge. Handb Exp Pharmacol. 2012;214:169\u201382. https:\/\/doi.org\/10.1007\/978-3-642-30726-3_9.","journal-title":"Handb Exp Pharmacol"},{"issue":"12","key":"175_CR16","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2165\/11594730-000000000-00000","volume":"28","author":"J Brannstrom","year":"2011","unstructured":"Brannstrom J, Hamberg K, Molander L, Lovheim H, Gustafson Y. Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey. Drugs Aging. 2011;28(12):993\u20131005. https:\/\/doi.org\/10.2165\/11594730-000000000-00000.","journal-title":"Drugs Aging"},{"issue":"4","key":"175_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1071\/HC14269","volume":"6","author":"A Schafers","year":"2014","unstructured":"Schafers A, Martini N, Moyes S, Hayman K, Zolezzi M, McLean C, et al. Medication use in community-dwelling older people: pharmacoepidemiology of psychotropic utilisation. J Prim Health Care. 2014;6(4):269\u201378.","journal-title":"J Prim Health Care"},{"issue":"3","key":"175_CR18","first-page":"e58","volume":"25","author":"GK Jasuja","year":"2019","unstructured":"Jasuja GK, Reisman JI, Weiner RS, Christopher ML, Rose AJ. Gender differences in prescribing of zolpidem in the Veterans Health Administration. Am J Manag Care. 2019;25(3):e58\u201365.","journal-title":"Am J Manag Care"},{"issue":"7\u20138","key":"175_CR19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1345\/aph.1M147","volume":"43","author":"K Johnell","year":"2009","unstructured":"Johnell K, Weitoft GR, Fastbom J. Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. Ann Pharmacother. 2009;43(7\u20138):1233\u20138. https:\/\/doi.org\/10.1345\/aph.1M147.","journal-title":"Ann Pharmacother"},{"key":"175_CR20","unstructured":"Methodology. WCCfDS. ATC classification index with DDDs. Oslo. 2018. https:\/\/www.whocc.no\/atc_ddd_index\/(2019)."},{"issue":"4","key":"175_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/fampra\/cmw030","volume":"33","author":"AA N\u2019Goran","year":"2016","unstructured":"N\u2019Goran AA, Blaser J, Deruaz-Luyet A, Senn N, Frey P, Haller DM, et al. From chronic conditions to relevance in multimorbidity: a four-step study in family medicine. Fam Pract. 2016;33(4):439\u201344. https:\/\/doi.org\/10.1093\/fampra\/cmw030.","journal-title":"Fam Pract"},{"issue":"1","key":"175_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2.","journal-title":"BMC Geriatr"},{"issue":"2","key":"175_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1046\/j.1532-5415.2001.49042.x","volume":"49","author":"JT Hanlon","year":"2001","unstructured":"Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49(2):200\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"175_CR24","doi-asserted-by":"publisher","first-page":"29597","DOI":"10.3402\/gha.v9.29597","volume":"9","author":"SP Phillips","year":"2016","unstructured":"Phillips SP, Hamberg K. Doubly blind: a systematic review of gender in randomised controlled trials. Global Health Action. 2016;9:29597. https:\/\/doi.org\/10.3402\/gha.v9.29597.","journal-title":"Global Health Action"},{"issue":"1","key":"175_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/eurheartj\/ehv598","volume":"37","author":"V Regitz-Zagrosek","year":"2016","unstructured":"Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A, et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37(1):24\u201334. https:\/\/doi.org\/10.1093\/eurheartj\/ehv598.","journal-title":"Eur Heart J"},{"issue":"31\u201332","key":"175_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3238\/arztebl.2010.0543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31\u201332):543\u201351. https:\/\/doi.org\/10.3238\/arztebl.2010.0543.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"175_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12875-017-0595-3","volume":"18","author":"NJ Pohontsch","year":"2017","unstructured":"Pohontsch NJ, Heser K, Loffler A, Haenisch B, Parker D, Luck T, et al. General practitioners\u2019 views on (long-term) prescription and use of problematic and potentially inappropriate medication for oldest-old patients\u2014a qualitative interview study with GPs (CIM-TRIAD study). BMC Fam Pract. 2017;18(1):22. https:\/\/doi.org\/10.1186\/s12875-017-0595-3.","journal-title":"BMC Fam Pract."},{"issue":"1","key":"175_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/13814788.2017.1395018","volume":"24","author":"K Selby","year":"2018","unstructured":"Selby K, Cornuz J, Cohidon C, Gaspoz JM, Senn N. How do Swiss general practitioners agree with and report adhering to a top-five list of unnecessary tests and treatments? Results of a cross-sectional survey. Eur J Gen Pract. 2018;24(1):32\u20138. https:\/\/doi.org\/10.1080\/13814788.2017.1395018.","journal-title":"Eur J Gen Pract"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-019-00175-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40801-019-00175-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-019-00175-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:51:32Z","timestamp":1608079892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40801-019-00175-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["175"],"URL":"https:\/\/doi.org\/10.1007\/s40801-019-00175-6","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,17]]},"assertion":[{"value":"17 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"David Schnegg, Nicolas Senn, Olivier Bugnon, Jo\u00eblle Schwarz and Yolanda Mueller have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the cantonal research committee (CER-VD 2016-00422) and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The AGE trial is funded by the Swiss National Science Foundation (Grand No. 32003B_159863\/1).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The datasets generated and\/or analysed during the current study are available from the corresponding author on reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}}]}}